Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-24T04:47:56.028Z Has data issue: false hasContentIssue false
  • English
  • Français

Conclusions of the Available Meta-Analyses Exploring the Efficacy of Levetiracetam

Published online by Cambridge University Press:  02 December 2014

Jose F. Tellez-Zenteno
Jose F. Tellez-Zenteno*
Affiliation:
University of Saskatchewan Saskatoon, Saskatchewan, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Editorial
Information
Canadian Journal of Neurological Sciences , Volume 38 , Issue 3 , May 2011 , pp. 388 - 389
Copyright
Copyright © The Canadian Journal of Neurological 2011

References

1 Lo, BWY, Kyu, HH, Jichichi, D, Upton, AM, Akl, EA, Meade, MO. Meta-analysis of randomized trials on first line and adjunctive levetiracetam. Can J Neurol Sci. 2011;38(3):475–86.Google Scholar
2 French, J, Edrich, P, Cramer, JA. A systematic review of the safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res. 2001;47:77–90.Google Scholar
3 Privitera, M. Efficacy of levetiracetam: a review of three pivotal clinical trials. Epilepsia. 2001;42 Suppl 4:31–5.Google Scholar
4 Leppik, I, Morrell, M, Godfroid, P, Arrigo, C. Seizure-free days observed in randomized placebo-controlled add-on trials with levetiracetam in partial epilepsy. Epilepsia. 2003;44:1350–2.Google Scholar
5 Leppik, IE, Biton, V, Sander, JW, Wieser, HG. Levetiracetam and partial seizure subtypes: pooled data from three randomized, placebo-controlled trials. Epilepsia. 2003;44:1585–7.Google Scholar
6 Cramer, JA, De, RK, Devinsky, O, Edrich, P, Trimble, MR. A systematic review of the behavioral effects of levetiracetam in adults with epilepsy, cognitive disorders, or an anxiety disorder during clinical trials. Epilepsy Behav. 2003;4:124–32.Google Scholar
7 Otoul, C, Arrigo, C, van, RK, French, JA. Meta-analysis and indirect comparisons of levetiracetam with other second-generation antiepileptic drugs in partial epilepsy. Clin Neuropharmacol. 2005;28:72–8.Google Scholar
8 Gidal, BE, Baltes, E, Otoul, C, Perucca, E. Effect of levetiracetam on the pharmacokinetics of adjunctive antiepileptic drugs: a pooled analysis of data from randomized clinical trials. Epilepsy Res. 2005;64:1–11.Google Scholar
9 Richy, FF, Banerjee, S, Brabant, Y, Helmers, S. Levetiracetam extended release and levetiracetam immediate release as adjunctive treatment for partial-onset seizures: an indirect comparison of treatment-emergent adverse events using metaanalytic techniques. Epilepsy Behav. 2009;16:240–5.Google Scholar